ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ready-to-transfer processes for a wide range of products.

Our high experience team is available for tailor-made projects for the most efficient solution. We are experts in trouble-shooting and in the set-up of manufacturing processes.

All platform technologies (cell lines and vaccines) ensure freedom-to-operate and are protected by patents and trade secrets. ARTES is available to negotiate exclusive license terms.

WHO recommendation, international registrations, FDA approvals and GRAS certifications are part of the track record achieved in our international collaborations. Large-scale manufacturing and full analytics in accordance with cGMP guidelines are warranted in collaboration with partners.